Atlas Trials

Surufatinib Combined With Chemotherapy Plus Toripalimab or Not in the Treatment of Small Cell Lung Cancer

Clinical trial NCT04996771 · UNKNOWN

Trial details

NCT number
NCT04996771
Sponsor
Sun Yat-sen University
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Small Cell Lung Carcinoma
Start date
2021-11-09
Primary completion
2023-12-31
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.